Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04459156 · ClinicalTrials.gov registry record · NA
Fiber Metabolism in Chronic Obstructive Pulmonary Disease
A NA study, sponsored by Texas A&M University.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT04459156 is a NA study that has completed, run by Texas A&M University. The registered enrollment target is 87 participants.
The verdict
NCT04459156, a NA study, has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
The impact of fiber intake on short chain fatty acid (SCFA) metabolism has not been studied in subjects suffering from COPD. The purpose of this study is to compare changes in SCFA metabolism after inulin vs. placebo intake in COPD patients to healthy matched controls. This protocol is an extension of a recent study about whole-body SCFA production rates in COPD patients. The investigators hypothesize that a short-term fiber supplementation increases SCFA production in COPD patients.
Interventions
- DIETARY_SUPPLEMENT Fiber Inulin
- DIETARY_SUPPLEMENT Placebo Maltodextrin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2020-06-23 |
| Est. Completion | 2023-03-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04459156
The ClinicalTrials.gov registry entry for NCT04459156 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas A&M University, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fiber Inulin is the first listed.
NCT04459156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04459156 about?
NCT04459156 is a clinical study titled "Fiber Metabolism in Chronic Obstructive Pulmonary Disease". The impact of fiber intake on short chain fatty acid (SCFA) metabolism has not been studied in subjects suffering from COPD. The purpose of this study is to compare changes in SCFA metabolism after inulin vs. placebo intake in COPD patients to healthy matched controls. This protocol is an extension ...
What is the current status of trial NCT04459156?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2020-06-23. Estimated completion is 2023-03-10.
What interventions are being tested in trial NCT04459156?
The interventions under investigation include: Fiber Inulin (DIETARY_SUPPLEMENT), Placebo Maltodextrin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04459156?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.